Edwards Lifesciences Overview

  • Founded
  • 1958
Founded
  • Status
  • Public
  • Employees
  • 14,900
Employees
  • Stock Symbol
  • EW
Stock Symbol
  • Investments
  • 37
  • Share Price
  • $94.63
  • (As of Monday Closing)

Edwards Lifesciences General Information

Description

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. Its key products include surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

Contact Information

Website
www.edwards.com
Formerly Known As
Edwards Laboratories, American Edwards Laboratories
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Monitoring Equipment
Other Industries
Other Devices and Supplies
Stock Exchange
NYS
Primary Office
  • One Edwards Way
  • Irvine, CA 92614
  • United States
+1 (949) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Edwards Lifesciences Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$94.63 $95.52 $66.23 - $98.11 $58.8B 622M 2.75M $1.36

Edwards Lifesciences Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 51,319,406 56,253,740 47,971,099 31,617,877
Revenue 4,474,200 4,386,300 4,348,000 3,722,800
EBITDA 1,053,200 1,016,300 1,244,300 836,700
Net Income 851,000 823,400 1,046,900 722,200
Total Assets 7,213,700 7,237,100 6,488,100 5,323,700
Total Debt 688,800 694,900 678,800 593,800
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Edwards Lifesciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Edwards Lifesciences‘s full profile, request access.

Request a free trial

Edwards Lifesciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical d
Monitoring Equipment
Irvine, CA
14,900 As of 2020
000
000000000 000

000000 0

modo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugi
00000000000 0000000
Marlborough, MA
00000 As of 0000
00000
000000&0

00000000

ectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim
00000 0000000000 0000000000 0000000
Minneapolis, MN
00000 As of 0000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Edwards Lifesciences Competitors (52)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Boston Scientific Corporation Marlborough, MA 00000 00000 000000&0
000000000 Corporation Minneapolis, MN 00000 00000000
0000000 Formerly VC-backed Kalamazoo, MI 00000 00000000
000000 000000 Corporation Warsaw, IN 00000 00.000 000000 - 000 00.000
0000000 Private Equity-Backed Farmingdale, NY 000 000.00 0000 000.00
You’re viewing 5 of 52 competitors. Get the full list »

Edwards Lifesciences Executive Team (34)

Name Title Board Seat Contact Info
Michael Mussallem Chief Executive Officer & Chairman
Scott Ullem Chief Financial Officer, Finance & Vice President
Robert Sellers Chief Accounting Officer, Accounting & Controller, Finance
Sal Chiovari Chief Information Officer
Steve Cohen Director, Corporate Strategy
You’re viewing 5 of 34 executive team members. Get the full list »

Edwards Lifesciences Board Members (13)

Name Representing Role Since
000000 00000 Self Board Member 000 0000
0000000 000000000 Edwards Lifesciences Chief Executive Officer & Chairman 000 0000
0000 000000 Self Board Member 000 0000
00000000 000000000 Self Board Member 000 0000
0000 0000000000 Self Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Edwards Lifesciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Edwards Lifesciences Investments & Acquisitions (37)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0-0000 22-Sep-2020 00000 00000 00 0000 Therapeutic Devices
0000000 000000 15-Jul-2020 00000 00000 00 0000 Decision/Risk Analysis
0000000 000000 28-Apr-2020 00000 00000 00 Decision/Risk Analysis
0000-00000 00000 18-Apr-2019 000000000000000000 00000 Monitoring Equipment 000000000 000000
Mitralign 12-Mar-2019 Merger/Acquisition Surgical Devices
You’re viewing 5 of 37 investments and acquisitions. Get the full list »

Edwards Lifesciences Subsidiaries (3)

Company Name Industry Location Founded
Valtech Cardio Surgical Devices Or Yehuda, Israel 2005
0000000 0000000000 Corporate Pension Irvine, CA 0000
0000-00000 00000 Monitoring Equipment Branford, CT 0000
To view Edwards Lifesciences’s complete subsidiaries history, request access »

Edwards Lifesciences Exits (11)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000000000 08-Dec-2014 00000 00000 00 0000 Completed
  • 9 buyers
000000 0000 000000 26-Jun-2013 00000 00000 00 000.00 Completed
  • 5 buyers
0000000000000 22-Feb-2013 00000 00000 00 0000 Completed
  • 9 buyers
000000 0000000 000 12-Apr-2010 00000 00000 00 00.00 Completed
  • 9 buyers
Vascular Architects 02-Nov-2004 Later Stage VC 000.00 Completed
  • 8 buyers
You’re viewing 5 of 11 exits. Get the full list »